Pfizer's Strategic Evolution in the Global Biopharma Landscape

Created using ChatSlide

This presentation delves into a New York-based company, established in 1849, which has expanded its market presence to over 200 countries, generating $62.6 billion in revenue by 2025. Notably, it offers a diverse array of products including Eliquis, Prevnar, and Comirnaty, alongside advanced AI tools and telemedicine platforms. The company's focus on cutting-edge solutions in oncology and immune health positions it as a leader in the healthcare sector. The discussion will integrate...